Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience

Corrado Girmenia, Anna Maria Frustaci, Giuseppe Gentile, +12

Haematologica

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

Massimo Breccia, Luca Mazzarella, Vincenzo Bagnardi, +11

Blood

“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia

Roberto Latagliata, Massimo Breccia, Ida Carmosino, +11

Leukemia Research

Hematological MalignancyOncologyOlder PatientsHematologyMyeloid Neoplasia +6

Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients

Massimo Breccia, Vincenzo Federico, Roberto Latagliata, +7

Leukemia Research

Myelodysplastic Syndrome PatientsHematological MalignancyBone Marrow FailureAplastic AnemiaClinical Epidemiology +7

Deferasirox treatment for myelodysplastic syndromes: “real-life” efficacy and safety in a single-institution patient population

Massimo Breccia, Paola Finsinger, Giuseppina Loglisci, +8

Annals of Hematology

Hematological MalignancySingle-institution Patient PopulationHematologyPharmacotherapyMedicine +3

Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib

Massimo Breccia, Giuseppina Loglisci, Adriano Salaroli, +5

Cancer Letters

Hematological MalignancyChromatinMajor Molecular ResponsesMedicineMixed-phenotype Acute Leukemia +9

COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report

Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, +46

British Journal of Haematology

Deferasirox Treatment Interruption in a Transfusion-Requiring Myelodysplastic Patient Led to Loss of Erythroid Response

Massimo Breccia, Giuseppina Loglisci, Adriano Salaroli, +3

Acta Haematologica

Erythroid ResponseIron MetabolismPharmacotherapyIron DeficiencyAplastic Anemia +15

LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

Massimo Breccia, Corrado Girmenia, Roberto Latagliata, +7

Mediterranean Journal of Hematology and Infectious Diseases

Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients

Massimo Breccia, Roberto Latagliata, Laura Cannella, +5

Leukemia & lymphoma/Leukemia and lymphoma

Prognostic FactorsRefractory AnemiaGynecologyPathologyRefractory Neutropenia +15